The Administrative Core (AC) of the UCLA ADRC provides coordination and integration of ADRC components and activities;oversees future planning and optimal utilization of resources;organizes support and advice for the ADRC Director and leadership;facilitates interaction between scientific and lay communities to develop relevant goals for the ADRC;coordinates and organizes external and internal advisory committee meetings;hosts the pilot project program;assures compliance with all IRB, animal welfare and HIPAA regulations, enhances interactions with other centers, the NACC, and outside research projects;ensures timely and routine transmission of appropriate UDS data to the NACC, interacts with other related research programs of UCLA;and coordinates with NIA media coverage of latest research findings from the Center. The AC has been instrumental in developing center wide consensus around The Therapeutic Imperative as the central focus of UCLA ADRC related activities. This focus provides a rationale for future planning, resource utilization, core activities, pilot project handling and project selection for this renewal application. The theme builds on well-developed capacities at UCLA for phenotype characterizations (e.g. Neuropsychiatric features) and neuroimging. The AC has been very successful at attracting donor support for UCLA ADRC activities in the past grant cycle and has developed strategies to pursue philanthropic support to leverage ADRC activities. AC leads interactions with relevant community programs (Alzheimer's Association, Leeza's Places), and other relevant activities at UCLA (Udall Center of Excellence for Parkinson's Disease, Center on Aging, Deane F. Johnson Center for Neurotherapeutics and others). The AC has been successful in attracting new investigators to the ADRC and in supporting junior investigators. The administrative structure of the UCLA ADRC has expanded to include John Ringman, MD as Assistant Director of the Center. Dr. Ringman will help provide leadership in the clinical arena, while Dr. Cole will continue as Associate Director, providing leadership in basic science and pilot project selection for the ADRC. The AC proposes several new initiatives in this renewal proposal, including a Board of Trustees, and enhanced collaborative activities with the Recruitment and Education Core and the NIA to disseminate research advances based on UCLA ADRC achievements. The AC is instrumental is developing a collaboration with Harbor UCLA Medical Center as a clinical satellite site in order to enhance minority enrollment.

Public Health Relevance

Approximately 5,000,000 people suffer from AD in the U.S. California is home to the largest U.S. population of elderly citizens;nearly one-third live in Los Angeles County. Projections indicate that by 2030 those over 65 will represent almost 20% of the county's population. There is an urgent need for AD research in Los Angeles to adequately diagnose and intervene against AD. This is the unifying focus of the UCLA ADRC.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4 (J2))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Los Angeles
United States
Zip Code
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Cruchaga, Carlos; Del-Aguila, Jorge L; Saef, Benjamin et al. (2018) Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement 14:205-214
Joe, Elizabeth; Medina, Luis D; Ringman, John M et al. (2018) 1H MRS spectroscopy in preclinical autosomal dominant Alzheimer disease. Brain Imaging Behav :
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360

Showing the most recent 10 out of 727 publications